Cathepsin Cysteine Protease Inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20090253672A1
SERIAL NO

12083474

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a novel class of compounds, represented by the formula (I) below, wherein the meanings of R1, R2, R3, R4, R5, R6, R7, X and Y are indicated therein, which are cysteine protease inhibitors, including but not limited to, inhibitors of cathepsms K L, S and B These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis, osteoarthritis and rheumatoid arthritis

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MERCK FROSST CANADA LTDQUEBEC CANADA QUEBEC

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bayly, Christopher Quebec , CA 16 104
Leger, Serge Quebec , CA 57 1487
Truchon, Jean-Francois Quebec , CA 7 41

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation